Stay updated with breaking news from Nasdaq Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UiPath (NASDAQ:PATH – Get Rating) had its target price dropped by equities researchers at BMO Capital Markets from $29.00 to $21.00 in a report issued on Thursday, The Fly reports. BMO Capital Markets’ price objective would indicate a potential upside of 7.64% from the company’s previous close. A number of other research firms also recently […]
UiPath (NASDAQ:PATH – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “UiPath Inc. offers an end-to-end platform for automation, combining Robotic Process Automation solution for digital business operations. UiPath Inc. is based in New […]
UiPath (NASDAQ:PATH – Get Rating) had its target price cut by stock analysts at KeyCorp from $34.00 to $23.00 in a report issued on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare company’s stock. KeyCorp’s price objective would indicate a potential upside of 28.13% from the company’s previous close. Several […]
UiPath (NASDAQ:PATH – Get Rating) and ANSYS (NASDAQ:ANSS – Get Rating) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability and risk. Profitability This table compares UiPath and ANSYS’s net margins, return on […]
UiPath (NASDAQ:PATH – Get Rating) is one of 403 publicly-traded companies in the “Prepackaged software” industry, but how does it contrast to its peers? We will compare UiPath to similar companies based on the strength of its risk, analyst recommendations, institutional ownership, profitability, earnings, dividends and valuation. Analyst Ratings This is a summary of recent […]